Shell Asset Management CO Ocular Therapeutix, Inc Transaction History

Shell Asset Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.01 - $5.22 $17,927 - $31,090	-5,956 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$4.83 - $7.35 $4,496 - $6,842	-931 Reduced 13.52%	5,956 $29,000
Q4 2021 Feb 09, 2022	SELL	$6.16 - $12.07 $591 - $1,158	-96 Reduced 1.37%	6,887 $48,000
Q3 2021 Nov 04, 2021	SELL	$9.7 - $14.34 $2,716 - $4,015	-280 Reduced 3.86%	6,983 $70,000
Q1 2021 May 10, 2021	BUY	$15.82 - $22.11 $114,900 - $160,584	7,263 New	7,263 $119,000

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.